ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Pediatric rheumatology"

  • Abstract Number: 0370 • ACR Convergence 2024

    Adolescents’ and Providers’ Perceptions of the Transition from Pediatric to Adult Rheumatology

    Julia Witowska, Brett Curtis, Melanie Donahue, Sara Platte, Rebecca Northway and Jacqueline Madison, University of Michigan, Ann Arbor, MI

    Background/Purpose: The transition from pediatric to adult rheumatology is a vulnerable period for adolescents and is associated with greater disease burden. Adolescents require an organized…
  • Abstract Number: 0398 • ACR Convergence 2024

    Validation of Patient-Reported Outcomes Measurement Information System® (PROMIS®) Pediatric Measures for Children with Chronic Nonbacterial Osteomyelitis Using the CHOIR Data

    Mary Eckert1, Eveline Wu2, Melissa Oliver3, Joshua Scheck4, Sivia Lapidus5, Ummusen Kaya Akca6, Shima Yasin7, Aleksander Lenert8, Sara Stern9, Antonella insalaco10, Manuela Pardeo10, Gabriele Simonini11, Edoardo Marrani12, Xing Wang13, Bin Huang14, Leonard Kovalick15, Natalie Rosenwasser16, Erin Balay-Dustrude17, Gabriel Casselman16, Liau Adriel18, Ava Klein18, Yurong Shao4, Claire Yang4, Molly Briggs4, Emily Deng4, Iris Hamilton4, Ethan Mueller16, Elise Machrone4, Paige Trunnel4, Doaa Mosa19, Lori Tucker20, Hermann Girschick21, Ronald Laxer22, Georgina Tiller23, Jonathan Akikusa24, Christian Hedrich25, Karen Onel26, Fatma Dedeoglu27, Marinka Twilt28, Seza Ozen29, Polly Ferguson30, Laura Schanberg31, Bryce Reeve32 and Yongdong (Dan) Zhao33, 1Seattle Children's, Mercer Island, WA, 2University of North Carolina School of Medicine, Chapel Hill, NC, 3Indiana University, Indianapolis, IN, 4Seattle Children's Hospital, Seattle, 5Hackensack University Medical Center, Montclair, NJ, 6Hacettepe University, Division of Pediatric Rheumatology, Department of Pediatrics, Faculty of Medicine, Ankara, Turkey, 7University of Iowa Carver College of Medicine, Abu Dhabi, United Arab Emirates, 8University of Iowa, Iowa City, IA, 9University of Utah, Salt Lake City, UT, 10IRCCS Ospedale Pediatrico Bambino Gesù, Rome, Italy, 11Meyer Children Hospital IRCCS; NEUROFARBA Department, University of Florence, Florence, Italy, 12University of Florence, Firenze, Florence, Italy, 13Biostatistics Epidemiology and Analytics in Research, Seattle Children’s Research Institute, Seattle, WA, 14Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cinciannati, OH, 15UNC Health Care, Durham, NC, 16Seattle Children's Hospital, Seattle, WA, 17University of Washington, Seattle, WA, 18Seattle Children’s Research Institute, University of Washington, Seattle, 19Mansoura University Hospital, Mansoura City, Egypt, 20BC Children's Hospital, Vancouver, BC, Canada, 21Vivantes Clinic Friedrichshain, Wuerzburg, Germany, 22SickKids, Toronto, ON, Canada, 23University of British Columbia - Vancouver, Vancouver, BC, Canada, 24Royal Children's Hospital, Parkville, Victoria, Australia, 25University of Liverpool, Liverpool, United Kingdom, 26HSS, New York, NY, 27Boston Children's Hospital, Boston, MA, 28Alberta Children's Hospital, Calgary, AB, Canada, 29Department of Pediatrics, Hacettepe University, Ankara, Turkey, 30University of Iowa Carver College of Medicine, Iowa City, IA, 31Duke University Medical Center, DURHAM, NC, 32Duke University School of Medicine, Durham, 33University of Washington, Redmond, WA

    Background/Purpose: Chronic nonbacterial osteomyelitis (CNO) is an autoinflammatory bone disease. It is critical to capture the child’s health-related quality of life impact using validated patient-reported…
  • Abstract Number: 0921 • ACR Convergence 2024

    Deep Immunologic Profiling of Trisomy 8-associated Autoinflammatory Disease (TRIAD)

    Kalpana Manthiram1, Lihong Shi1, Yue Zhang2, Bayu Sisay3, Shouguo Gao4, Zhijie Wu4, Qin Xu1, Mary Bowes2, Laura Failla2, Neelam Redekar2, Abdel Elkahloun3, Pamela Schwartzberg1 and Daniel Kastner3, 1National Institute of Allergy and Infectious Disease, Bethesda, MD, 2National Institute of Allergy and Infectious Diseases, Bethesda, MD, 3National Human Genome Research Institute, Bethesda, MD, 4National Heart, Lung, and Blood Institute, Bethesda, MD

    Background/Purpose: Trisomy 8 mosaicism is associated with an inflammatory disease characterized by recurrent fever and oral, genital, and gastrointestinal ulcers, resembling Behçet’s disease. Little is…
  • Abstract Number: 1266 • ACR Convergence 2024

    Anti-Mitochondrial Antibodies Associate with Disease Activity and IFNα Expression in Childhood-onset Systemic Lupus Erythematosus

    Marina Barguil Macedo1, Javad Wahadat2, Albin Bjoerk3, Sylvia Kamphuis2, Marjan Versnel2 and Christian Lood1, 1University of Washington, Seattle, WA, 2Erasmus University Medical Center, Rotterdam, Netherlands, 3Karolinska Institutet, Stockholm, Sweden

    Background/Purpose: Extracellular mitochondria may represent a source of antigenic burden in autoimmune disorders, such as in systemic lupus erythematosus (SLE), in which those organelles, released…
  • Abstract Number: 1284 • ACR Convergence 2024

    Unlocking Insights into Juvenile Dermatomyositis: Clinical and Demographic Profiles Paired with Total Improvement Scores at a Tertiary Center

    keerthivardhan yerram1, phanikumar devarasetti1 and Liza Rajasekhar2, 1Nizams institute of medical sciences, hyderabad, Andhra Pradesh, India, 2Nizam's Institute of Medical Sciences, Madhapur, Andhra Pradesh, India

    Background/Purpose: Juvenile dermatomyositis (JDM) is a rare autoimmune disorder that predominantly affects the skin and muscles in children under the age of sixteen. Literature on…
  • Abstract Number: 1771 • ACR Convergence 2024

    Characterization of Pathogenic Immune Mechanisms in Oligoarticular Juvenile Idiopathic Arthritis Applying Single-cell Transcriptomics and Proteomics

    Mireia Lopez Corbeto1, yolanda Guillen2, Irene Bonafonte3, Nuria Palau4, Raül Tortosa4, Estefanía Moreno Ruzafa1, Antonio Julia5 and Sara Marsal6, 1Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain, 2Imidomics, Inc, Barcelona, Spain, 3Berufserfahrung: Helmholtz Munich, Barcelona, Spain, 4Vall d´Hebron Hospital Research Institute, Rheumatology, Barcelona, Spain, 5Vall d'Hebron Hospital Research Institute, Barcelona, Spain, 6Vall Hebron Hospital Research Institute, Barcelona, Spain

    Background/Purpose: Juvenile idiopathic arthritis (JIA) is a prevalent rheumatic disease in children, comprising seven subtypes. The most common, oligoarticular JIA (oJIA), accounts for 30-60% of…
  • Abstract Number: 1937 • ACR Convergence 2024

    Wellness and Burnout Among Pediatric Rheumatologists in North America- A 2024 CARRA Study

    Kathryn Cook1, Aviya Lanis2, Arielle Hay3, Daniel Glaser4, Sarah Hoffmann5, Lakshmi Moorthy6, Onengiya Harry7, Deepika Singh8 and Sheetal Vora9, and for the CARRA Investigators, 1Akron Children's Hospital, Akron, OH, 2Seattle Children's Hospital, Seattle, WA, 3Nicklaus Children's Hospital, Hollywood, FL, 4Yale University School of Medicine, New Haven, CT, 5Children's Hospital of Richmond at VCU, Richmond, VA, 6Rutgers Robert Wood Johnson Medical School, Metuchen, NJ, 7Brenner Children's Hospital - Wake Forest Baptist Health, Winston-Salem, NC, 8Valley Children's Healthcare, Clovis, CA, 9Atrium Health Levine Children's Hospital, Charlotte, NC

    Background/Purpose: A high proportion of pediatricians experience burnout symptom impacting patient care and academic productivity. Burnout is a state of physical, emotional or mental exhaustion…
  • Abstract Number: 2190 • ACR Convergence 2024

    Uncovering Inborn Errors of Immunity in Pediatric Rheumatology

    Maleewan Kitcharoensakkul1, Natsumon Udomkittivorakul1, Tarin Bigley1, Lance Peterson2, Kevin Baszis3 and Megan Cooper2, 1Washington University in St. Louis, St. Louis, 2Washington University School of Medicine, St. Louis, MO, 3Washington Univ in St. Louis School of Medicine, St Louis, MO

    Background/Purpose: Immune dysregulation, including autoimmunity, is one of the known clinical manifestations of inborn errors of immunity (IEI). We aim to evaluate IEI discovered by…
  • Abstract Number: 2343 • ACR Convergence 2024

    Temporal Trends in and Associations with NSAID Prescription in Adult and Pediatric Patients with IBD

    Adam Mayer1, Rui Xiao2, Andrew Grossman3, Meenakshi Bewtra4, Michael George2 and Pamela Weiss5, 1University of Pennsylvania/Children's Hospital of Philadelphia, Philadelphia, PA, 2University of Pennsylvania, Philadelphia, PA, 3Children's Hospital of Philadelphia, Philadelphia, 4University of Pennsylvania, Philadelphia, 5Children's Hospital of Philadelphia, Philadelphia, PA

    Background/Purpose: The role of nonsteroidal anti-inflammatory drugs (NSAIDs) in the management of musculoskeletal symptoms in patients with inflammatory bowel disease (IBD) and IBD-associated arthritis remains…
  • Abstract Number: 2625 • ACR Convergence 2024

    Brain Injury Markers Correlate with Impaired Executive Function and Disease Activity in Children with Systemic Lupus Erythematosus

    Oscar Mwizerwa1, Justine Ledochowski2, Tala El Tal3, Ganesh Ramanathan2, Sarah Mossad4, Ibrahim Mohamed5, Joanna Law6, Lawrence Ng2, Paris Moaf2, Asha Jeyanathan1, Adrienne Davis7, Ann Yeh2, Linda Hiraki2, Deborah Levy2, Zahi Touma8, Joan Wither9, Busi Zapparoli10, Ashley Danguecan11 and Andrea Knight12, 1The Hospital for Sick Children, Division of Rheumatology, Department of Paediatrics, University of Toronto, The Hospital for Sick Children, Neurosciences and Mental Health, Research Institute, Toronto, ON, Canada, 2The Hospital for Sick Children, Toronto, ON, Canada, 3The Hospital For Sick Children & Children's Hospital of Eastern Ontario (CHEO), Ottawa, ON, The Hospital for Sick Children, Division of Rheumatology, Department of Paediatrics, University of Toronto, Toronto, ON, Canada, 4Hospital for Sick Children, Toronto, ON, Canada, 5The Hospital for Sick Children, Brampton, ON, Canada, 6The Hospital for Sick Children, Division of Rheumatology, Department of Paediatrics, University of Toronto, Toronto, ON, Canada, 7Division of Pediatric Emergency Medicine, Department of Pediatrics, Hospital for Sick Children and University of Toronto, Toronto, ON, Canada, 8University of Toronto, Toronto, ON, Canada, 9University Health Network, Toronto, ON, Canada, 10The Hospital for Sick Children, Etobicoke, ON, Canada, 11The Hospital for Sick Children, Department of Psychology, University of Toronto, Toronto, ON, Canada, 12Division of Rheumatology, The Hospital for Sick Children; Neurosciences and Mental Health, SickKids Research Institute; Department of Paediatrics, University of Toronto, Toronto, ON, Canada

    Background/Purpose: Patients with childhood-onset systemic lupus erythematosus (cSLE) commonly experience impaired executive function (EF), and attribution to neuropsychiatric lupus (NPSLE) is challenging. Serum markers of…
  • Abstract Number: 0377 • ACR Convergence 2024

    Improving Self-Management Support in Patients with Juvenile Idiopathic Arthritis

    Julia Harris1, Leslie Favier2, Emily Fox3, Michael Holland3, Cara Hoffart4, Maria Ibarra3, Jordan Jones4, Susan Parish2, Kara Remick-Erickson2 and Ashley Cooper4, 1Children's Mercy Kansas City, Overland Park, KS, 2Children's Mercy Kansas City, Kansas City, 3Children's Mercy Hospital, Kansas City, MO, 4Children's Mercy Kansas City, Kansas City, MO

    Background/Purpose: Self-management support (SMS) is one of the key elements of the Chronic Care Model as it is an important aspect of the care for…
  • Abstract Number: 0399 • ACR Convergence 2024

    Eosinophilia and Exposure to IL-1 and IL-6 Blocking Biologic Medications in a Systemic Juvenile Idiopathic Arthritis Patient Cohort

    Rachel Dickey1, Doel Dhar2, Srushti Gangireddy3, Henry H. Ong3, Wei-Qi Wei3 and Anna Patrick3, 1Lipscomb University College of Pharmacy, Athens, TN, 2Monroe Carell Jr Children's Hospital at Vanderbilt, Nashville, TN, 3Vanderbilt University Medical Center, Nashville, TN

    Background/Purpose: Systemic juvenile idiopathic arthritis (SJIA) is a severe disease with symptoms of fevers, rash, and arthritis. High levels of the inflammatory cytokines interlukin-1 (IL-1)…
  • Abstract Number: 1026 • ACR Convergence 2024

    Healthcare Utilization and Childhood Opportunity Index in Patients with Juvenile Idiopathic Arthritis and Systemic Lupus Erythematosus

    Julia Harris1, Ashley Cooper2 and Luke Harris2, 1Children's Mercy Kansas City, Overland Park, KS, 2Children's Mercy Kansas City, Kansas City, MO

    Background/Purpose: Juvenile idiopathic arthritis (JIA) and systemic lupus erythematosus (SLE) are chronic autoimmune diseases that can be complicated by significant morbidity. There are also known…
  • Abstract Number: 1267 • ACR Convergence 2024

    Antiphospholipid Antibody-related Clinical Manifestations Presenting During Childhood versus Adulthood: Descriptive Results from the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository (“Registry”)

    Jheel Pandya1, Danieli Andrade2, Ann E. Clarke3, Maria Tektonidou4, Vittorio Pengo5, Massimo Radin6, Jose Pardos-Gea7, Nina Kello8, Diana Paredes-Ruiz9, Mª Angeles Aguirre-Zamorano10, H Michael Belmont11, Paul Fortin12, Flavio Victor Signorelli13, TATSUYA ATSUMI14, Zhuoli Zhang15, Maria Efthymiou16, David Branch17, Giulia Pazzola18, Angela Tincani19, Ali Duarte-Garcia20, Esther Rodriguez-Almaraz21, Michelle Petri22, Ricard Cervera23, Bahar Artim Esen24, Guillermo Pons-Estel25, Hui Shi26, Yu Zuo27, Rohan Willis28, Pierluigi Meroni29, Robert Roubey30, Maria Laura Bertolaccini31, Hannah Cohen32 and Doruk Erkan1, and on behalf of APS ACTION, 1Hospital for Special Surgery, New York, NY, 2University of São Paulo, São Paulo, SP, Brazil, 3Division of Rheumatology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada, 4National and Kapodistrian University of Athens, Athens, Greece, 5Thrombosis Research Laboratory, Department of Cardio-Thoracic-Vascular Sciences and Public Health, University of Padova, Padova, Italy, 6University of Turin, Turin, Italy, 7Vall d'Hebron University Hospital, Barcelona, Spain, 8Northwell Health, Brooklyn, NY, 9Autoimmune Diseases Research Unit. Biocruces Bizkaia Health Research Institute, Baracaldo, Spain, 10IMIBIC/Reina Sofia Hospital/University of Cordoba, CÓRDOBA, Andalucia, Spain, 11NYU School of Medicine, New York, NY, 12Centre ARThrite - CHU de Québec - Université Laval, Quebec, QC, Canada, 13Universidade do Estado do Rio de Janeiro, Rio De Janeiro, Brazil, 14Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan, 15Peking University First Hospital, Beijing, China, 16University College London, London, United Kingdom, 17University of Utah and Intermountain Healthcare, Salt Lake City, UT, 18Rheumatology Unit, Azienda USL IRCCS di Reggio Emilia, Reggio Emilia, Italy, 19ASST Spedali Civili-University of Brescia, Brescia, Italy, 20Mayo Clinic, Rochester, MN, 21Hospital Universitario 12 de Octubre, Madrid, Spain, 22Johns Hopkins University School of Medicine, Timonium, MD, 23Hospital Clinic de Barcelona, Barcelona, Spain, 24Istanbul University, Istanbul Faculty of Medicine, Division of Rheumatology, Istanbul, Turkey, 25CREAR, Rosario, Argentina, 26Department of Rheumatology and lmmunology, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China, Shanghai, China (People's Republic), 27University of Michigan, Ann Arbor, MI, 28University of Texas Medical Branch, Galveston, TX, 29IRCCS Istituto Auxologico Italiano 100%, Cusano Milanino, Milan, Milan, Italy, 30Division of Rheumatology, Allergy, and Immunology, University of North Carolina, Chapel Hill, NC, 31King's College London, London, United Kingdom, 32University College London Hospitals NHS Foundation Trust, London, United Kingdom

    Background/Purpose: APS ACTION Registry studies long-term outcomes in persistently antiphospholipid antibody (aPL)-positive patients with/without other systemic autoimmune rheumatic diseases. Given autoimmune diseases present differently in…
  • Abstract Number: 1285 • ACR Convergence 2024

    The Impact of Race and Social Determinants of Health on Patient Reported Outcomes in Pediatric Lupus: A CARRA Registry Study

    William Soulsby1, Rebecca Olveda2, Jie He3, Laura Berbert4, Edie Weller3, Kamil Barbour5, Kurt Greenlund5, Laura Schanberg6, Emily Von Scheven1, Aimee Hersh7, Mary Beth Son8, Joyce Chang8 and Andrea Knight9, and the CARRA Registry Investigators, 1University of California, San Francisco, San Francisco, CA, 2Palo Alto Medical Foundation, Dublin, CA, 3Boston Children's Hospital, Boston, MA, 4Boston Children's Hospital, Belmont, MA, 5CDC, Alpharetta, GA, 6Duke University Medical Center, DURHAM, NC, 7University of Utah, Salt Lake City, UT, 8Boston Children's Hospital, Brookline, MA, 9Division of Rheumatology, The Hospital for Sick Children; Neurosciences and Mental Health, SickKids Research Institute; Department of Paediatrics, University of Toronto, Toronto, ON, Canada

    Background/Purpose: Minoritized race and social determinants of health (SDoH) are associated with lower achievement of the low lupus disease activity state (LLDAS) and higher cumulative…
  • 1
  • 2
  • 3
  • …
  • 52
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology